Abstract
The DNA methylation pattern of a cell is exquisitely controlled during early development resulting in distinct methylation patterns. The tight control of DNA methylation is released in the cancer cell characterized by a reversal of methylation states. CpG island associated genes, in particular tumour suppressor or related genes, are often hypermethylated and this is associated with silencing of these genes. Therefore methylation is commonly convicted as a critical causal event in silencing this important class of genes in cancer. In this review, we argue that methylation is not the initial guilty party in triggering gene silencing in cancer, but that methylation of CpG islands is a consequence of prior gene silencing, similar to the role of methylation in maintaining the silencing of CpG island genes on the inactive X chromosome. We propose that gene silencing is the critical precursor in cancer, as it changes the dynamic interplay between de novo methylation and demethylation of the CpG island and tilts the balance to favour hypermethylation and chromatin inactivation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Aggerholm A, Guldberg P, Hokland M, Hokland P . 1999 Cancer Res. 59: 436–441
Alves G, Tatro A, Fanning T . 1996 Gene 176: 39–44
Antequera F, Bird A . 1993 Proc. Natl. Acad. Sci. USA 90: 11995–11999
Baylin SB, Esteller M, Rountree MR, Bachman KE, Schuebel K, Herman JG . 2001 Hum. Mol. Genet. 10: 687–692
Baylin SB, Herman JG . 2000 Trends Genet. 16: 168–174
Baylin SB, Herman J, Graff JR, Vertino PM, Issa JP . 1998 Advances in Cancer Research In Vandewoude GF and Klein G (eds) Academic Press Inc,: San Diego, CA pp. 141–196
Belinsky SA, Nikula KJ, Baylin SB, Issa JP . 1996 Proc. Natl. Acad. Sci. USA 93: 4054–4060
Bestor T, Laudano A, Mattaliano R, Ingram V . 1988 J. Mol. Biol. 203: 971–983
Bestor TH, Tycko B . 1996 Nature Genet. 12: 363–367
Bird A . 1992 Cell 70: 5–8
Bird AP . 1986 Nature 321: 209–213
Bird AP, Wolffe AP . 1999 Cell 99: 451–454
Brandeis M, Frank D, Keshet I, Siegfried Z, Mendelsohn M, Nemes A, Temper V, Razin A, Cedar H . 1994 Nature 371: 435–438
Cameron EE, Baylin SB, Herman JG . 1999 Blood 94: 2445–2451
Cervoni N, Szyf M . 2001 J. Biol. Chem. 276: 40778–40787
Chen RZ, Pettersson U, Beard C, Jackson-Grusby L, Jaenisch R . 1998 Nature 395: 89–93
Costello JF, Fruhwald MC, Smiraglia DJ, Rush LJ, Robertson GP, Gao X, Wright FA, Feramisco JD, Peltomaki P, Lang JC, Schuller DE, Yu L, Bloomfield CD, Caligiuri MA, Yates A, Nishikawa R, Huang HJS, Petrelli NJ, Zhang XL, O'Dorisio MS, Held WA, Cavenee WK, Plass C . 2000 Nature Genet. 24: 132–138
Costello JF, Plass C . 2001 J. Med. Genet. 38: 285–303
Csankovszki G, Nagy A, Jaenisch R . 2001 J. Cell. Biol. 153: 773–784
De Smet C, Lurquin C, Lethe B, Martelange V, Boon T . 1999 Mol. Cell. Biol. 19: 7327–7335
Ehrlich M . 2000 J. Clin. Ligand Assay 23: 144–146
Feinberg AP, Vogelstein B . 1983 Nature 301: 89–92
Gardiner-Garden M, Frommer M . 1987 J. Mol. Biol. 196: 261–282
Gitan RS, Shi H, Chen CM, Yan PS, Huang TH . 2002 Genome Res. 12: 158–164
Holliday R, Pugh JE . 1975 Science 187: 226–232
Howlett SK, Reik W . 1991 Development 113: 119–127
Huschtscha LI, Noble JR, Neumann AA, Moy EL, Barry P, Melki JR, Clark SJ, Reddel RR . 1998 Cancer Res. 58: 3508–3512
Iguchi-Ariga SMM, Schaffner W . 1989 Genes Dev. 3: 612–619
Issa J, Vertino PM, Wu JJ, Sazawal S, Celano P, Nelkin BD, Hamilton SR, Baylin SB . 1993 J. Nat. Cancer Inst. 85: 1235–1240
Jones PA . 1999 Trends Genet. 15: 34–37
Jones PA, Laird PW . 1999 Nature Genet. 21: 163–167
Jost J-P, Frémont M, Siegmann M, Hofsteenge J . 1997 Nucleic Acids Res. 25: 4545–4550
Kass SU, Pruss D, Wolffe AP . 1997 Trends Genet. 13: 444–449
Laird PW, Jackson-Grusby L, Fazeli A, Dickinson SL, Jung WE, Li E, Weinberg RA, Jaenisch R . 1995 Cell 81: 197–205
Lee PJ, Washer LL, Law DJ, Boland CR, Horon IL, Feinberg AP . 1996 Proc. Natl. Acad. Sci. USA 93: 10366–10370
Lee W-H, Morton RA, Epstein JI, Brooks JD, Campbell PA, Bova GS, Hsieh W-S, Isaacs WB, Nelson WG . 1994 Proc. Natl. Acad. Sci. USA 91: 11733–11737
Li E, Bestor TH, Jaenisch R . 1992 Cell 69: 915–926
Macleod D, Charlton J, Mullins J, Bird AP . 1994 Gene Dev. 8: 2282–2292
Mayer W, Niveleau A, Walter J, Fundele R, Haaf T . 2000 Nature 403: 501–502
Melki JM, Vincent PC, Clark SJ . 1999 Cancer Res. 59: 3730–3740
Melki JR, Vincent PC, Brown RD, Clark SJ . 2000 Blood 95: 3208–3213
Melki JR, Warnecke P, Vincent PC, Clark SJ . 1998 Leukemia 12: 311–316
Mermoud JE, Popova B, Peters AH, Jenuwein T, Brockdorff N . 2002 Curr. Biol. 12: 247–251
Millar DS, Ow KK, Paul CL, Russell PJ, Molloy PL, Clark SJ . 1999 Oncogene 18: 1313–1324
Millar DS, Paul CL, Molloy PL, Clark SJ . 2000 J. Biol. Chem. 275: 24893–24899
Mizuno S, Chijiwa T, Okamura T, Akashi K, Fukumaki Y, Niho Y, Sasaki H . 2001 Blood 97: 1172–1179
Molloy PL, Watt F . 1990 Philos. Trans. R. Soc. Lond. B. Biol. Sci. 326: 267–275
Monk M . 1990 Philos. Trans. R. Soc. Lond. [Biol.] 326: 299–312
Monk M, Boubelik M, Lehnert S . 1987 Development 99: 371–382
Morgan HD, Sutherland HG, Martin DI, Whitelaw E . 1999 Nature Genet. 23: 314–318
Nan XS, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN, Bird A . 1998 Nature 393: 386–389
Noble JR, Rogan EM, Neumann AA, Maclean K, Bryan TM, Reddel RR . 1996 Oncogene 13: 1259–1268
Okano M, Bell DW, Haber DA, Li E . 1999 Cell 99: 247–257
Okano M, Xie S, Li E . 1998 Nature Genet. 19: 219–220
Pfeifer GP, Tanguay RL, Steigerwald SD, Riggs AD . 1990 Genes Dev. 4: 1277–1287
Pogribny IP, Miller BJ, James SJ . 1997 Cancer Lett. 115: 31–38
Reik W, Dean W, Walter J . 2001 Science 293: 1089–1093
Riggs AD . 1975 Cytogenet. Cell. Genet. 14: 9–25
Robertson KD, Uzvolgyi E, Liang G, Talmadge C, Sumegi J, Gonzales FA, Jones PA . 1999 Nucleic Acids Res. 27: 2291–2298
Schmutte C, Yang AS, Nguyen TT, Beart RW, Jones PA . 1996 Cancer Res. 56: 2375–2381
Schwarz S, Bourgeois C, Soussaline F, Homsy C, Podesta A, Jost JP . 2000 Eur. J. Cell Biol. 79: 488–494
Song J, Stirzaker C, Harrison J, Melki J, Clark S . 2002 Oncogene 21: 1048–1061
Stern LL, Mason JB, Selhub J, Choi SW . 2000 Cancer Epidemiol. Biomarkers Prev. 9: 849–853
Stirzaker C, Millar DS, Paul CL, Warnecke PM, Harrison J, Vincent PC, Frommer M, Clark SJ . 1997 Cancer Res. 57: 2229–2237
Thayer RE, Singer MF, Fanning TG . 1993 Gene 133: 273–277
Vachtenheim J, Horakova I, Novotna H . 1994 Cancer Res. 54: 1145–1148
Warnecke P . 1998 PhD thesis, DNA Methylation in Early Development, University of Sydney, Sydney
Warnecke P, Mann J, Frommer M, Clark S . 1998 Genomics 51: 182–190
Warnecke PM, Clark SJ . 1999 Mol. Cell. Biol. 19: 164–172
Wu JJ, Issa JP, Herman J, Bassett DE, Nelkin BD, Baylin SB . 1993 Proc. Natl. Acad. Sci. USA 90: 8891–8895
Xu GL, Bestor TH, Bourchis D, Hsieh CL, Tommerup N, Bugge M, Hulten M, Qu XY, Russo JJ, ViegasPequignot E . 1999 Nature 402: 187–191
Yoder JA, Walsh CP, Bestor TH . 1997 Trends Genet. 13: 335–340
Acknowledgements
We would like to thank Clare Stirzaker, Jenny Song, Peter Warnecke and Peter Molloy for valuable comments. This work was supported in part by grants from NH&MRC (9937987, 000454 and 202907).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Clark, S., Melki, J. DNA methylation and gene silencing in cancer: which is the guilty party?. Oncogene 21, 5380–5387 (2002). https://doi.org/10.1038/sj.onc.1205598
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205598
Keywords
This article is cited by
-
Potential antioxidant effects of Narcissus tazetta phenolic compounds against cadmium chloride–induced hepatotoxicity in Swiss albino mice
Environmental Science and Pollution Research (2021)
-
CTCF loss mediates unique DNA hypermethylation landscapes in human cancers
Clinical Epigenetics (2020)
-
Epigenetic crosstalk in chronic infection with HIV-1
Seminars in Immunopathology (2020)
-
Genome-wide DNA methylation profiles in Tibetan and Yorkshire pigs under high-altitude hypoxia
Journal of Animal Science and Biotechnology (2019)
-
A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia
Nature Communications (2018)